DISTRI CARE PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DISTRI CARE PHARMA
Largest movements
- Receivables within one year +€95,989
up €95,989 (+22.8%), from €421,333 to €517,322
of which Trade receivables: +€55,895
- Intangible fixed assets -€51,046
down €51,046 (-27.9%), from €183,179 to €132,133
- Stocks and contracts +€12,008
up €12,008 (+16.5%), from €72,850 to €84,858
- Contributions +€296,900
up €296,900 (+792%), from €37,500 to €334,400
- Debts after one year -€293,218
down €293,218 (-75.7%), from €387,218 to €94,000
- Profit (loss) carried forward +€53,170
up €53,170 (+14.2%), from -€375,600 to -€322,430
- Trade debts -€41,533
down €41,533 (-14.7%), from €282,321 to €240,788
- Short-term financial debts +€33,874
up €33,874 (+16.6%), from €203,917 to €237,790
- Staff costs -€283,533
down €283,533 (-73.3%), from €386,577 to €103,044
- Gross operating margin -€36,387
down €36,387 (-13.5%), from €269,124 to €232,737
- Depreciation -€15,175
down €15,175 (-22.2%), from €68,428 to €53,254
- Financial charges -€8,021
down €8,021 (-26.5%), from €30,269 to €22,248
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €702,642 | €750,448 | +€47,806 | +6.8% |
| Fixed assets | 21/28 | €197,260 | €144,007 | -€53,254 | -27.0% |
| Intangible fixed assets | 21 | €183,179 | €132,133 | -€51,046 | -27.9% |
| Tangible fixed assets | 22/27 | €4,952 | €2,745 | -€2,207 | -44.6% |
| Furniture and vehicles | 24 | €4,952 | €2,745 | -€2,207 | -44.6% |
| Financial fixed assets | 28 | €9,129 | €9,129 | = | 0.0% |
| Current assets | 29/58 | €505,381 | €606,441 | +€101,060 | +20.0% |
| Stocks and contracts in progress | 3 | €72,850 | €84,858 | +€12,008 | +16.5% |
| Stocks | 30/36 | €72,850 | €84,858 | +€12,008 | +16.5% |
| Amounts receivable within one year | 40/41 | €421,333 | €517,322 | +€95,989 | +22.8% |
| Trade receivables | 40 | €210,439 | €266,335 | +€55,895 | +26.6% |
| Other amounts receivable | 41 | €210,893 | €250,987 | +€40,094 | +19.0% |
| Cash at bank and in hand | 54/58 | €9,289 | €3,124 | -€6,165 | -66.4% |
| Deferred charges and accrued income | 490/1 | €1,910 | €1,137 | -€773 | -40.5% |
| Total equity and liabilities | 10/49 | €702,642 | €750,448 | +€47,806 | +6.8% |
| Equity | 10/15 | -€334,350 | €11,970 | +€346,320 | |
| Contributions | 10/11 | €37,500 | €334,400 | +€296,900 | +792% |
| Reserves | 13 | €3,750 | - | -€3,750 | |
| Non-distributable reserves | 130/1 | €3,750 | - | -€3,750 | |
| Reserves not available under the articles | 1311 | €3,750 | - | -€3,750 | |
| Profit (loss) carried forward | 14 | -€375,600 | -€322,430 | +€53,170 | +14.2% |
| Amounts payable | 17/49 | €1,036,991 | €738,477 | -€298,514 | -28.8% |
| Amounts payable after more than one year | 17 | €387,218 | €94,000 | -€293,218 | -75.7% |
| Financial debts | 170/4 | €387,218 | €94,000 | -€293,218 | -75.7% |
| Amounts payable within one year | 42/48 | €649,773 | €644,477 | -€5,296 | -0.8% |
| Financial debts | 43 | €203,917 | €237,790 | +€33,874 | +16.6% |
| Credit institutions | 430/8 | €203,917 | €237,790 | +€33,874 | +16.6% |
| Trade debts | 44 | €282,321 | €240,788 | -€41,533 | -14.7% |
| Suppliers | 440/4 | €282,321 | €240,788 | -€41,533 | -14.7% |
| Taxes, remuneration and social security | 45 | €118,675 | €128,093 | +€9,418 | +7.9% |
| Taxes | 450/3 | €95,132 | €101,295 | +€6,163 | +6.5% |
| Remuneration and social security | 454/9 | €23,544 | €26,798 | +€3,254 | +13.8% |
| Other amounts payable | 47/48 | €44,861 | €37,806 | -€7,054 | -15.7% |
| Remuneration, social security and pensions | 62 | €386,577 | €103,044 | -€283,533 | -73.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €68,428 | €53,254 | -€15,175 | -22.2% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | €186 | +€186 | |
| Other operating charges | 640/8 | €100 | €800 | +€700 | +698% |
| Gross operating margin | 9900 | €269,124 | €232,737 | -€36,387 | -13.5% |
| Operating profit (loss) | 9901 | -€185,982 | €75,454 | +€261,436 | |
| Financial income | 75/76B | €2 | - | -€2 | |
| Recurring financial income | 75 | €2 | - | -€2 | |
| Financial charges | 65/66B | €30,269 | €22,248 | -€8,021 | -26.5% |
| Recurring financial charges | 65 | €30,269 | €22,248 | -€8,021 | -26.5% |
| Profit (loss) for the period before taxes | 9903 | -€216,249 | €53,206 | +€269,455 | |
| Income taxes | 67/77 | €412 | €36 | -€377 | -91.3% |
| Profit (loss) for the period | 9904 | -€216,661 | €53,170 | +€269,832 | |
| Profit (loss) for the period to be appropriated | 9905 | -€216,661 | €53,170 | +€269,832 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.